Gastrointestinal Bleeding

Bleeding occurs when injury, inflammation, ulceration, a vascular abnormality, or another lesion disrupts blood vessels in the digestive tract. The resulting blood loss may be visible through hematemesis, melena, or hematochezia, or remain occult and become apparent through its effects, such as anemia. Identifying the lesion helps clinicians connect the bleeding pattern with its underlying cause.

Occult bleeding may lack obvious blood in vomit or stool, yet ongoing loss can still produce anemia and indicate a potentially serious lesion. This makes clinical assessment important even without dramatic visible findings. Laboratory testing, history, physical examination, and risk assessment help identify consequences and determine how urgently further evaluation is needed.

These visible findings provide different ways for bleeding to present during clinical evaluation: hematemesis refers to blood in vomit, melena to altered blood in stool, and hematochezia to visible blood passed rectally. They help characterize the event, but evaluation still requires broader assessment because bleeding can also remain occult and the source must be located.

Controlling active blood loss is only one part of care. Because gastrointestinal bleeding can arise from mucosal injury, inflammation, ulceration, vascular abnormalities, or other lesions, clinicians also need to manage the underlying cause. This approach supports prevention of recurrence rather than relying solely on immediate control of bleeding.

Evaluation combines a focused history, physical examination, laboratory testing, and risk assessment before or alongside procedures used to locate the source. These steps help clinicians recognize anemia or hemodynamic instability, judge the seriousness of the presentation, and select appropriate next actions. Endoscopy may then provide direct source identification and guide treatment.

Endoscopy helps locate the bleeding source within the digestive tract and can guide targeted hemostasis, meaning direct control of active bleeding. Its value extends beyond identifying where blood is coming from: source localization supports more focused treatment and helps clinicians connect the observed presentation with the lesion responsible.

It requires prompt clinical attention when blood loss produces anemia, hemodynamic instability, or concern for serious disease. In these situations, clinicians prioritize recognition and resuscitation, then use evaluation and endoscopy to identify the source and guide targeted hemostasis. Managing the underlying cause and planning prevention of recurrence complete the clinical approach.